What attracted Cardinal Health to ALARIS?
ALARIS represents an opportunity for Cardinal Health to develop a much more robust product offering in the medication safety marketplace. We have a presence at the patient bedside that complements the role Cardinal Health fills in pharmacies, surgical suites and other major locations within hospitals. Additionally, our sales force and distribution network outside the U.S. will be a major new asset for Cardinal Health, which presently derives less than 10% of its revenues from international markets. As we learned more about Cardinal Health’s values and culture and how closely aligned they are with ours, we became even more convinced that by working together, we could make a much more significant impact on medication safety than either of us could on our own. We could also see how the acquisition will create new opportunities for employees. How much is the company being sold for? The company is being sold for approximately $2 billion, which includes the assumption of about $350 million o
